Kidney Cancer
Specialized kidney cancer treatment combining immunotherapy, targeted therapy, and surgical options.
Overview
Kidney cancer, particularly renal cell carcinoma, has seen dramatic advances in treatment with immunotherapy and targeted drug combinations. Our team uses molecular profiling to select the optimal systemic therapy and coordinates closely with urologic surgeons for cases requiring surgical management.
For patients with metastatic disease, novel immunotherapy combinations have significantly improved outcomes, and we offer access to clinical trials testing the next generation of treatments.
Symptoms & Warning Signs
- Blood in the urine
- Pain in the side or lower back
- A mass or lump in the side or abdomen
- Unexplained weight loss
- Fatigue and intermittent fever
Diagnosis & Evaluation
Imaging
CT scan, MRI, and ultrasound
Biopsy
Core needle biopsy when indicated
Molecular Profiling
Histologic subtyping and biomarker analysis
Treatment Options
Frequently Asked Questions
Is kidney cancer curable?
When caught early and confined to the kidney, surgical removal is often curative. Even advanced kidney cancer now has significantly improved survival with modern immunotherapy and targeted therapy combinations.
What are TKI drugs?
Tyrosine kinase inhibitors (TKIs) are targeted drugs that block specific enzymes cancer cells need to grow. They are a cornerstone of advanced kidney cancer treatment, often combined with immunotherapy.
